Mitochondria and reactive oxygen species in renal cancer

Biochimie

Volumn 89, Issue 9, 2007, Pages 1080-1088

  Hervouet, Eric ^a   Simonnet, Hélène ^a   Godinot, Catherine ^a  

^a CNRS   (France)

Author keywords

Cancer; Mitochondria; Oxidative phosphorylation; Reactive oxygen species

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; BIOGENESIS; CANCER CELL CULTURE; CELL HYPOXIA; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; MITOCHONDRIAL MEMBRANE; OXIDATIVE PHOSPHORYLATION; RESPIRATORY CHAIN; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; APOPTOSIS; HUMANS; KIDNEY NEOPLASMS; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDATIVE PHOSPHORYLATION; REACTIVE OXYGEN SPECIES;

EID: 34547844296     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2007.03.010     Document Type: Article

References (100)

1. Warburg O., Wind F., and Neglers E. In: Warburg O. (Ed). Metabolism of Tumours (1930), Constable and Co, London 254-270
2. Warburg O. On the origin of cancer cells. Science 123 (1956) 309-314
3. Pedersen P.L. Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor Res. 22 (1978) 190-274
4. Simonnet H., Alazard N., Pfeiffer K., Gallou C., Beroud C., Demont J., Bouvier R., Schägger H., and Godinot C. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23 (2002) 759-768
5. Cuezva J.M., Krajewska M., de Heredia M.L., Krajewski S., Santamaria G., Kim H., Zapata J.M., Marusawa H., Chamorro M., and Reed J.C. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 62 (2002) 6674-6681
6. Iliopoulos O., Kibel A., Gray S., and Kaelin Jr. W.G. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1 (1995) 822-826
7. Iliopoulos O., Levy A.P., Jiang C., Kaelin Jr. W.G., and Goldberg M.A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 10595-10599
8. Kaelin W.G., and Maher E.R. The VHL tumour-suppressor gene paradigm. Trends Genet. 14 (1998) 423-426
9. Dang C.V., and Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 2 (1999) 68-72
10. Bustamante E., and Pedersen P.L. High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 3735-3739
11. Mathupala S.P., Ko Y.H., and Pedersen P.L. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25 (2006) 4777-4786
12. Fiore C., Trezeguet V., Le Saux A., Roux P., Schwimmer C., Dianoux A.C., Noel F., Lauquin G.J., Brandolin G., and Vignais P.V. The mitochondrial ADP/ATP carrier: structural, physiological and pathological aspects. Biochimie 80 (1998) 137-150
13. Nury H., Dahout-Gonzalez C., Trezeguet V., Lauquin G.J., Brandolin G., and Pebay-Peyroula E. Relations between structure and function of the mitochondrial ADP/ATP carrier. Annu. Rev. Biochem. 75 (2006) 713-741
14. Issartel J.P., Dupuis A., Garin J., Lunardi J., Michel L., and Vignais P.V. The ATP synthase (F0-F1) complex in oxidative phosphorylation. Experientia 48 (1992) 351-362
15. Saraste M. Oxidative phosphorylation at the fin de siecle. Science 283 (1999) 1488-1493
16. Faure Vigny H., Heddi A., Giraud S., Chautard D., and Stepien G. Expression of oxidative phosphorylation genes in renal tumors and tumoral cell lines. Mol. Carcinog. 16 (1996) 165-172
17. Unwin R.D., Craven R.A., Harnden P., Hanrahan S., Totty N., Knowles M., Eardley I., Selby P.J., and Banks R.E. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 3 (2003) 1620-1632
18. Kim W., and Kaelin Jr. W.G. The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer. Curr. Opin. Genet. Dev. 13 (2003) 55-60
19. Kaelin W.G. The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing. Cold Spring Harbor Symp. Quant. Biol. 70 2005 (2005) 159-166
20. Berra E., Ginouves A., and Pouyssegur J. The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep. 7 (2006) 41-45
21. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
22. Fantin V.R., St-Pierre J., and Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology and tumor maintenance. Cancer Cell 9 (2006) 425-434
23. Ullah M.S., Davies A.J., and Halestrap A.P. The plasma membrane lactate transporter MCT4 but not MCT1 is up-regulated by hypoxia through a HIF-1 alpha-dependent mechanism. J. Biol. Chem. 281 (2006) 9030-9037
24. Pedersen P.L., Mathupala S., Rempel A., Geschwind J.F., and Ko Y.H. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim. Biophys. Acta. 1555 (2002) 14-20
25. Gwak G.Y., Yoon J.H., Kim K.M., Lee H.S., Chung J.W., and Gores G.J. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J. Hepatol. 42 (2005) 358-364
26. Wenger R.H., Stehl D.P., and Camenish G. Integration of oxygen signaling at the consensus HRE. Sci. STKE. 306 (2005) re 12
27. Bardos J.I., and Ashcroft M. Negative and positive regulation of HIF-1: a complex network. Biochim. Biophys. Acta. 1755 (2005) 107-120
28. Kim J.W., Tchernyshyov I., Semenza G.L., and Dang C.V. HIF-1 mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3 (2006) 177-185
29. Papandreou I., Cairns R.A., Fontana L., Lim A.L., and Denko N.C. HIF1 mediated adaptationto hypoxia by actively down-regulating mitochondrial oxygen consumption. Cell Metab. 3 (2006) 187-197
30. Shaw R.J. Glucose metabolism and cancer. Curr. Opin. Cell Biol. 18 (2006) 598-608
31. Meierhofer D., Mayr J.A., Foetschl U., Berger A., Fink K., Schmeller N., Hacker G.W., Hauser-Kronberger C., Kofler B., and Sperl W. Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis 25 (2004) 1005-1010
32. Shi T., Dong F., Liou L.S., Duan Z.H., Novick A.C., and DiDonato J.A. Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 40 (2004) 47-61
33. Craven R.A., Hanrahan S., Totty N., Harnden P., Stanley A.J., Maher E.R., Harris A.L., Trimble W.S., Selby P.J., and Banks R.E. Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma. Proteomics 6 (2006) 3880-3893
34. Craven R.A., Stanley A.J., Hanrahan S., Dods J., Unwin R., Totty N., Harnden P., Eardley I., Selby P.J., and Banks R.E. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics 6 (2006) 2853-2864
35. Cuezva J.M., Chen G., Alonso A.M., Isidoro A., Misek D.E., Hanash S.M., and Beer D.G. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis 25 (2004) 1157-1163
36. Isidoro A., Martinez M., Fernandez P.L., Ortega A.D., Santamaria G., Chamorro M., Reed J.C., and Cuezva J.M. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem. J. 378 (2004) 17-20
37. Rossignol R., Gilkerson R., Aggeler R., Yamagata K., Remington S.J., and Capaldi R.A. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64 (2004) 985-993
38. Simonnet H., Demont J., Pfeiffer K., Guenaneche L., Bouvier R., Brandt U., Schägger H., and Godinot C. Mitochondrial complex I is deficient in renal oncocytomas. Carcinogenesis 24 (2003) 1461-1466
39. Hervouet E., Demont J., Pecina P., Vojtiskova A., Houstek J., Simonnet H., and Godinot C. A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis. Carcinogenesis 26 (2005) 531-539
40. Jiang Y., Zhang W., Kondo K., Klco J.M., St Martin T.B., Dufault M.R., Madden S.L., Kaelin Jr. W.G., and Nacht M. Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol. Cancer Res. 1 (2003) 453-462
41. Liou L.S., Shi T., Duan Z.H., Sadhukhan P., Der S.D., Novick A.A., Hissong J., Skacel M., Almasan A., and DiDonato J.A. Microarray gene expression profiling and analysis in renal cell carcinoma. BMC Urol. 22 (2004) 4-9
42. Jones J., Out H., Spentzos D., Kolia S., Inan M., Beecken W.D., Fellbaum C., Gu X., Joseph M., Pantuck A.J., Jonas D., and Libermann T.A. Gene signatures of progression and metastasis in renal cell cancer. Clin. Cancer Res. 11 (2005) 5730-5739
43. Hervouet, E., PhD thesis, Lyon, France, 2006.
44. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., and Hwang P.M. p53 regulates mitochondrial respiration. Science 312 (2006) 1650-1653
45. Stiburek L., Vesela K., Hansikova H., Pecina P., Tesarova M., Cerna L., Houstek J., and Zeman J. Tissue-specific cytochrome c oxidase assembly defects due to mutations in SCO2 and SURF1. Biochem. J. 392 (2005) 625-632
46. Zisman A., Pantuck A.J., Bui M.H., Said J.W., Caliliw R.R., Rao N., Shintaku P., Berger F., Gambhir S.S., and Belldegrun A.S. LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen. Cancer Res. 63 (2003) 4952-4959
47. Sumiyoshi Y., Kakeji Y., Egashira A., Mizokami K., Orita H., and Maehara Y. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin. Cancer Res. 12 (2006) 5112-5117
48. Pecina P., Houstkova H., Hansikova H., Zeman J., and Houstek J. Genetic defects of cytochrome c oxidase assembly. Physiol. Res. 53 Suppl 1 (2004) S213-S223
49. Lehtonen R., Kiuru M., Vanharanta S., Sjoberg J., Aaltonen L.M., Aittomaki K., Arola J., Butzow R., Eng C., Husgafvel-Pursiainen K., Isola J., Jarvinen H., Koivisto P., Mecklin J.P., Peltomaki P., Salovaara R., Wasenius V.M., Karhu A., Launonen V., Nupponen N.N., and Aaltonen L.A. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am. J. Pathol. 164 (2004) 17-22
50. Astuti D., Latif F., Dallol A., Dahia P.L., Douglas F., George E., Skoldberg F., Husebye E.S., Eng C., and Maher E.R. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69 (2001) 49-54
51. Baysal R.E., Ferrell J.E., Willett-Brozick E.C., Lawrence D., Myssiorek A., Bosch A., van der Mey P.E., Taschner W.S., Rubinstein E.N., Myers C.W., Richard III, Cornelisse C.J., Devilee P., and Devlin B. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287 (2000) 848-851
52. Niemann S., and Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 26 (2000) 268-270
53. Pollard P.J., Briere J.J., Alam N.A., Barwell J., Barclay E., Wortham N.C., Hunt T., Mitchell M., Olpin S., Moat S.J., Hargreaves I.P., Heales S.J., Chung Y.L., Griffiths J.R., Dalgleish A., McGrath J.A., Gleeson M.J., Hodgson S.V., Poulsom R., Rustin P., and Tomlinson I.P. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14 (2005) 2231-2239
54. Bourgeron T., Rustin P., Chretien D., Birch-Machin M., Bourgeois M., Viegas-Pequignot E., Munnich A., and Rotig A. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat. Genet. 11 (1995) 144-149
55. Ishii N., Fujii M., Hartman P.S., Tsuda M., Yasuda K., Senoo-Matsuda N., Yanase S., Ayusawa D., and Suzuki K. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 394 (1998) 694-697
56. Senoo-Matsuda N., Yasuda K., Tsuda M., Ohkubo T., Yoshimura S., Nakazawa H., Hartman P.S., and Ishii N. A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J. Biol. Chem. 276 (2001) 41553-41558
57. Brandon M., Baldi P., and Wallace D.C. Mitochondrial mutations in cancer. Oncogene 25 (2006) 4647-4662
58. Boveris A., Cadenas E., and Stoppani A.O. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem. J. 156 (1976) 435-444
59. Turrens J.F., Alexandre A., and Lehninger A.L. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch. Biochem. Biophys. 237 (1985) 408-414
60. Fleury C., Mignotte B., and Vayssière J.-L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84 (2002) 131-141
61. Liu Y., Fiskum G., and Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J. Neurochem. 80 (2002) 780-787
62. Herrero A., and Barja G. H2O2 production of heart mitochondria and aging rate are slower in canaries and parakeets than in mice: sites of free radical generation and mechanisms involved. Mech. Ageing Dev. 103 (1998) 133-146
63. St-Pierre J., Buckingham J.A., Roebuck S.J., and Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277 (2002) 44784-44790
64. Lambert A.J., and Brand M.D. Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J. Biol. Chem. 279 (2004) 39414-39420
65. Korshunov S.S., Skulachev V.P., and Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 416 (1997) 15-18
66. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 9 (2005) 359-407
67. Santamaria G., Martinez-Diez M., Fabregat I., and Cuezva J.M. Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase. Carcinogenesis 27 (2006) 925-935
68. Copeland W.C., Wachsman J.T., Johnson F.M., and Penta J.S. Mitochondrial DNA alterations in cancer. Cancer Invest. 20 (2002) 557-569
69. Durham S.E., Krishnan K.J., Betts J., and Birch-Machin M.A. Mitochondrial DNA damage in non-melanoma skin cancer. Br. J. Cancer 88 (2003) 90-95
70. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., Lim S., Issa M.M., Flanders W.D., Hosseini S.H., Marshall F.F., and Wallace D.C. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 719-724
71. Bonora E., Porcelli A.M., Gasparre G., Biondi A., Ghelli A., Carelli V., Baracca A., Tallini G., Martinuzzi A., Lenaz G., Rugolo M., and Romeo G. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer Res. 66 (2006) 6087-6096
72. Nishikawa M., Oshitani N., Matsumoto T., Nishigami T., Arakawa T., and Inoue M. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. Br. J. Cancer 93 (2005) 331-337
73. Moreno-Loshuertos R., Acin-Perez R., Fernandez-Silva P., Movilla N., Perez-Martos A., Rodriguez de Cordoba S., Gallardo M.E., and Enriquez J.A. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat. Genet. 38 (2006) 1261-1268
74. Butler J., Jayson G.G., and Swallow A.J. The reaction between the superoxide anion radical and cytochrome c. Biochim. Biophys. Acta. 408 (1975) 215-222
75. Beyer R.E. An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochem. Cell. Biol. 70 (1992) 390-403
76. Ham A.J., and Liebler D.C. Vitamin E oxidation in rat liver mitochondria. Biochemistry 34 (1995) 5754-5761
77. Okado-Matsumoto A., and Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J. Biol. Chem. 276 (2001) 38388-38393
78. Geller B.L., and Winge D.R. Subcellular distribution of superoxide dismutases in rat liver. Methods Enzymol. 105 (1984) 105-114
79. Liochev S.I., and Fridovich I. Superoxide and iron: partners in crime. IUBMB Life 48 (1999) 157-161
80. Dhaunsi G.S., Singh I., Orak J.K., and Singh A.K. Antioxidant enzymes in ciprofibrate-induced oxidative stress. Carcinogenesis 15 (1994) 1923-1930
81. Liu R., Oberley T.D., and Oberley L.W. Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. Hum. Gene Ther. 8 (1997) 585-595
82. Behrend L., Henderson G., and Zwacka R.M. Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 31 (2003) 1441-1444
83. Zhu X., Raina A.K., Perry G., and Smith M.A. Apoptosis in Alzheimer disease: a mathematical improbability. Curr. Alzheimer Res. 4 (2006) 393-396
84. Bernardi P., Broekemeier K.M., and Pfeiffer D.R. Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembr. 26 (1994) 509-517
85. Appaix F., Guerrero K., Rampal D., Izikki M., Kaambre T., Sikk P., Brdiczka D., Riva-Lavieille C., Olivares J., Longuet M., Antonsson B., and Saks V.A. Bax and heart mitochondria: uncoupling and inhibition of respiration without permeability transition. Biochim. Biophys. Acta. 1556 (2002) 155-167
86. Campello S., De Marchi U., Szabo I., Tombola F., Martinou J.C., and Zoratti M. The properties of the mitochondrial megachannel in mitoplasts from human colon carcinoma cells are not influenced by Bax. FEBS Lett. 579 (2005) 3695-3700
87. Pelicano H., Carney D., and Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Update (2004) 97-110
88. Dias N., and Bailly C. Drugs targeting mitochondrial functions to control tumor cell growth. Biochem. Pharmacol. 70 (2005) 1-12
89. Moreira P.I., Custodio J., Moreno A., Oliveira C.R., and Santos M.S. Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure. J. Biol. Chem. 281 (2006) 10143-10152
90. Zhao K., Luo G., Gianelli S., and Szeto H.H. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem. Pharmacol. 70 (2005) 1796-1806
91. Migliaccio E., Giorgio M., and Pelicci P.G. Apoptosis and aging: role of p66shc redox protein. Antioxidants Redox Signal 8 (2006) 600-608
92. Madesh M., and Hajnoczky G. VDAC-dependant permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J. Cell. Biol. 155 (2001) 1003-1016
93. Li Q., Sato E.F., Kira Y., Nishikawa M., Utsumi K., and Inoue M. A possible cooperation of SOD1 and cytochrome c in mitochondria-dependent apoptosis. Free Radic. Biol. Med. 10 (2006) 173-181
94. Starkov A.A., Polster B.M., and Fiskum G. Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax. J. Neurochem. 83 (2002) 220-228
95. D'Alessio M., De Nicola M., Coppola S., Gualandi G., Pugliese L., Cerella C., Cristofanon S., Civitareale P., Ciriolo M.R., Bergamaschi A., Magrini A., and Ghibelli L. Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis. FASEB J. 19 (2005) 1504-1506
96. Gottlieb E., Vander Heiden M.G., and Thompson C.B. Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol. Cell. Biol. 20 (2000) 5680-5689
97. Tyurina Y.Y., Kini V., Tyurin V.A., Vlasova I.I., Jiang J., Kapralov A.A., Belikova N.A., Yalowich J.C., Kurnikov I.V., and Kagan V.E. Mechanisms of cardiolipin oxidation by cytochrome c: relevance to pro- and anti-apoptotic functions of etoposide. Mol. Pharmacol. 70 (2006) 706-717
98. Iverson S.L., Enoksson M., Gogvadze V., Ott M., and Orrenius S. Cardiolipin is not required for Bax-mediated cytochrome c release from yeast mitochondria. J. Biol. Chem. 279 (2004) 1100-1107
99. Iverson S.L., and Orrenius S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch. Biochem. Biophys. 423 (2004) 37-46
100. Paradies G., Petrosillo G., Pistolese M., and Ruggiero M. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett. 466 (2000) 323-326